GLP-1s Are Changing the Dental Visit
By McKenna Franks, RDH
Originally at decisionsindentistry.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
GLP-1 medications are now common in dental patients and directly affect xerostomia, enamel erosion, aspiration risk, and potentially oral health outcomes, requiring practice owners and clinical teams to update screening and chair-side protocols.
Key points
- GLP-1 agonists are linked to xerostomia and enamel erosion, increasing caries and erosion risk during routine visits.
- Aspiration risk rises in patients on GLP-1 therapy, prompting changes in patient positioning and suction protocols.
- Emerging evidence suggests GLP-1 drugs may confer oral health benefits, creating new counseling points for hygienists and dentists.
- Decisions in Dentistry identifies these medication-related considerations as a new standard of care for oral health professionals.
Who should care
Read the original on Decisions in Dentistry
Full reporting and any paywall content live on decisionsindentistry.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Pennsylvania brothers facing 400 years for racketeering conspiracy, $32M Medicaid fraud; RFK Jr. undergoes surgery; GLP-1 users still love chocolate treats - Morning Medical Update
- ·Regulatory
Democrats plan to add vision, hearing, dental to Medicare
- ·Regulatory
FDA warns public about unauthorized direct-to-consumer clear aligners
- ·Regulatory
ADA, CDA collaboration helps protect Proposition 56 dental funding